Supporting Safer Healthcare

Prior to the establishment of the new National Hemovigilance Program in February, 2010, the U.S. was the only developed country without an established method to nationally track and aggregate adverse events associated with blood transfusions. The program is part of the National Healthcare Safety Network of the Centers for Disease Control (CDC), and allows all U.S. hospitals that transfuse [...]